Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.12 USD 1.5% Market Closed
Market Cap: 1.1B USD

Intrinsic Value

The intrinsic value of one AUPH stock under the Base Case scenario is 10.72 USD. Compared to the current market price of 8.12 USD, Aurinia Pharmaceuticals Inc is Undervalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AUPH Intrinsic Value
10.72 USD
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Aurinia Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
AUPH
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AUPH cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
CA
Biotechnology
Market Cap
1.1B USD
IPO
Jul 16, 2001
CA
Biotechnology
Market Cap
1.1B USD
IPO
Jul 16, 2001
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Aurinia Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aurinia Pharmaceuticals Inc

Current Assets 446.6m
Cash & Short-Term Investments 358.4m
Receivables 36.5m
Other Current Assets 51.6m
Non-Current Assets 104m
PP&E 98.9m
Intangibles 4.4m
Other Non-Current Assets 823k
Efficiency

Free Cash Flow Analysis
Aurinia Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aurinia Pharmaceuticals Inc

Revenue
235.1m USD
Cost of Revenue
-28.2m USD
Gross Profit
206.9m USD
Operating Expenses
-188.5m USD
Operating Income
18.4m USD
Other Expenses
-12.7m USD
Net Income
5.8m USD
Fundamental Scores

AUPH Profitability Score
Profitability Due Diligence

Aurinia Pharmaceuticals Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROE is Increasing
ROIC is Increasing
40/100
Profitability
Score

Aurinia Pharmaceuticals Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

AUPH Solvency Score
Solvency Due Diligence

Aurinia Pharmaceuticals Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
75/100
Solvency
Score

Aurinia Pharmaceuticals Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AUPH Price Targets Summary
Aurinia Pharmaceuticals Inc

Wall Street analysts forecast AUPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AUPH is 10.17 USD with a low forecast of 8.08 USD and a high forecast of 12.6 USD.

Lowest
Price Target
8.08 USD
0% Downside
Average
Price Target
10.17 USD
25% Upside
Highest
Price Target
12.6 USD
55% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Aurinia Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AUPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AUPH Insider Trading
Buy and sell transactions by insiders

AUPH News

What is the Intrinsic Value of one AUPH stock?

The intrinsic value of one AUPH stock under the Base Case scenario is 10.72 USD.

Is AUPH stock undervalued or overvalued?

Compared to the current market price of 8.12 USD, Aurinia Pharmaceuticals Inc is Undervalued by 24%.

Back to Top